Why the study?
Leadless pacemaker implantation is increasingly considered in pediatric patients as an alternative to conventional pacemakers, particularly when femoral venous access is not feasible.
Is transjugular intravenous leadless pacemaker implantation safe and effective in pediatric patients with inadequate femoral venous access?
Is transjugular intravenous leadless pacemaker implantation safe and effective in pediatric patients with inadequate femoral venous access?
The internal jugular vein approach represents a safe and effective alternative for leadless pacemaker implantation in selected pediatric patients when femoral access is contraindicated.
May enable leadless pacemaker use via internal jugular access in select children; leaves open need for prospective safety data.
Leadless pacemaker (LPM) implantation in pediatric patients is increasingly considered as an alternative to conventional pacemakers, especially when femoral venous access is not feasible. We present the case of a 7-year-old child with Mobitz type II second-degree atrioventricular block who successfully underwent LPM implantation via the right internal jugular vein due to inadequate femoral vein diameter. A comprehensive literature review was conducted to summarize the outcomes of internal jugular vein approach in children. The transjugular approach demonstrates several advantages, including suitability for larger sheaths, reduced vascular complications, shorter implantation path, stable mid-septal positioning, and faster recovery. Preoperative evaluation of venous anatomy and patient-specific factors is critical. Although pericardial effusion and sensing issues may occur, the internal jugular vein represents a safe and effective alternative for LPM implantation in selected pediatric patients when femoral access is contraindicated.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: